Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells

Li Zhang, Yi Zhang, Xiao Yuan Liu, Zheng Hong Qin, Jin Ming Yang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aim:To determine whether elongation factor-2 kinase (eEF-2 kinase) contributes to the malignant phenotype of glioblastoma multiforme by promoting the migration and invasion of glioma cells. The mechanism involved was also explored.Methods:Human glioma cell lines T98G and LN-229 were used. The expression of eEF-2 kinase was silenced using siRNA, and the invasive potential of tumor cells was assessed using a wound-healing assay and a Matrigel invasion assay. Apoptosis was determined using propidium iodide (PI) staining and Western blot analysis of cleaved caspase-3.Results:Silencing the expression of eEF-2 kinase by siRNA significantly suppressed both the migration and invasion of human glioma cells. Silencing eEF-2 kinase expression also sensitized glioma cells to anoikis, thereby decreasing tumor cell viability in the absence of attachment. Treatment of tumor cells with the caspase inhibitor z-VAD-fmk down-regulated Bim accumulation and abolished glioma cell sensitivity to anoikis.Conclusion:The results suggest that the expression of eEF-2 kinase contributes to migration and invasion of human glioma cells by protecting them from anoikis. eEF-2 kinase expression may serve as a prognostic marker and a novel target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)361-367
Number of pages7
JournalActa Pharmacologica Sinica
Volume32
Issue number3
DOIs
StatePublished - Mar 1 2011

Fingerprint

Elongation Factor 2 Kinase
Anoikis
Glioma
Phosphotransferases
Small Interfering RNA
Neoplasms
Caspase Inhibitors
Propidium
Glioblastoma
Caspase 3
Wound Healing
Cell Survival
Western Blotting
Apoptosis
Staining and Labeling
Phenotype
Cell Line

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Zhang, Li ; Zhang, Yi ; Liu, Xiao Yuan ; Qin, Zheng Hong ; Yang, Jin Ming. / Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells. In: Acta Pharmacologica Sinica. 2011 ; Vol. 32, No. 3. pp. 361-367.
@article{6a7333f6f4c742f191fa7d8b481c333d,
title = "Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells",
abstract = "Aim:To determine whether elongation factor-2 kinase (eEF-2 kinase) contributes to the malignant phenotype of glioblastoma multiforme by promoting the migration and invasion of glioma cells. The mechanism involved was also explored.Methods:Human glioma cell lines T98G and LN-229 were used. The expression of eEF-2 kinase was silenced using siRNA, and the invasive potential of tumor cells was assessed using a wound-healing assay and a Matrigel invasion assay. Apoptosis was determined using propidium iodide (PI) staining and Western blot analysis of cleaved caspase-3.Results:Silencing the expression of eEF-2 kinase by siRNA significantly suppressed both the migration and invasion of human glioma cells. Silencing eEF-2 kinase expression also sensitized glioma cells to anoikis, thereby decreasing tumor cell viability in the absence of attachment. Treatment of tumor cells with the caspase inhibitor z-VAD-fmk down-regulated Bim accumulation and abolished glioma cell sensitivity to anoikis.Conclusion:The results suggest that the expression of eEF-2 kinase contributes to migration and invasion of human glioma cells by protecting them from anoikis. eEF-2 kinase expression may serve as a prognostic marker and a novel target for cancer therapy.",
author = "Li Zhang and Yi Zhang and Liu, {Xiao Yuan} and Qin, {Zheng Hong} and Yang, {Jin Ming}",
year = "2011",
month = "3",
day = "1",
doi = "10.1038/aps.2010.213",
language = "English (US)",
volume = "32",
pages = "361--367",
journal = "Acta Pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "3",

}

Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells. / Zhang, Li; Zhang, Yi; Liu, Xiao Yuan; Qin, Zheng Hong; Yang, Jin Ming.

In: Acta Pharmacologica Sinica, Vol. 32, No. 3, 01.03.2011, p. 361-367.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells

AU - Zhang, Li

AU - Zhang, Yi

AU - Liu, Xiao Yuan

AU - Qin, Zheng Hong

AU - Yang, Jin Ming

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Aim:To determine whether elongation factor-2 kinase (eEF-2 kinase) contributes to the malignant phenotype of glioblastoma multiforme by promoting the migration and invasion of glioma cells. The mechanism involved was also explored.Methods:Human glioma cell lines T98G and LN-229 were used. The expression of eEF-2 kinase was silenced using siRNA, and the invasive potential of tumor cells was assessed using a wound-healing assay and a Matrigel invasion assay. Apoptosis was determined using propidium iodide (PI) staining and Western blot analysis of cleaved caspase-3.Results:Silencing the expression of eEF-2 kinase by siRNA significantly suppressed both the migration and invasion of human glioma cells. Silencing eEF-2 kinase expression also sensitized glioma cells to anoikis, thereby decreasing tumor cell viability in the absence of attachment. Treatment of tumor cells with the caspase inhibitor z-VAD-fmk down-regulated Bim accumulation and abolished glioma cell sensitivity to anoikis.Conclusion:The results suggest that the expression of eEF-2 kinase contributes to migration and invasion of human glioma cells by protecting them from anoikis. eEF-2 kinase expression may serve as a prognostic marker and a novel target for cancer therapy.

AB - Aim:To determine whether elongation factor-2 kinase (eEF-2 kinase) contributes to the malignant phenotype of glioblastoma multiforme by promoting the migration and invasion of glioma cells. The mechanism involved was also explored.Methods:Human glioma cell lines T98G and LN-229 were used. The expression of eEF-2 kinase was silenced using siRNA, and the invasive potential of tumor cells was assessed using a wound-healing assay and a Matrigel invasion assay. Apoptosis was determined using propidium iodide (PI) staining and Western blot analysis of cleaved caspase-3.Results:Silencing the expression of eEF-2 kinase by siRNA significantly suppressed both the migration and invasion of human glioma cells. Silencing eEF-2 kinase expression also sensitized glioma cells to anoikis, thereby decreasing tumor cell viability in the absence of attachment. Treatment of tumor cells with the caspase inhibitor z-VAD-fmk down-regulated Bim accumulation and abolished glioma cell sensitivity to anoikis.Conclusion:The results suggest that the expression of eEF-2 kinase contributes to migration and invasion of human glioma cells by protecting them from anoikis. eEF-2 kinase expression may serve as a prognostic marker and a novel target for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=79952377033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952377033&partnerID=8YFLogxK

U2 - 10.1038/aps.2010.213

DO - 10.1038/aps.2010.213

M3 - Article

C2 - 21278783

AN - SCOPUS:79952377033

VL - 32

SP - 361

EP - 367

JO - Acta Pharmacologica Sinica

JF - Acta Pharmacologica Sinica

SN - 1671-4083

IS - 3

ER -